XORTX Therapeutics (STU:ANUA) OCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ANUA XORTX Therapeutics Inc STU:ANUA
26 GF Score
Price €1.75
! 1 Warning Sign
View Full Analysis

What is XORTX Therapeutics OCF Margin %?

XORTX Therapeutics STU:ANUA -0.79% 26 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:ANUA with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 950 Biotechnology companies, XORTX Therapeutics ranks worse than 105263.05% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. XORTX Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was €-0.43 Mil. XORTX Therapeutics's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, XORTX Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, XORTX Therapeutics's current OCF Yield % is -70.75%.

The historical rank and industry rank for XORTX Therapeutics's OCF Margin % or its related term are showing as below:


STU:ANUA's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -65.71
* Ranked among companies with meaningful OCF Margin % only.

XORTX Therapeutics OCF Margin % Related Terms

XORTX Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for XORTX Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XORTX Therapeutics OCF Margin % Chart

XORTX Therapeutics Annual Data
Trend Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XORTX Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:ANUA
26GF Score
XORTX Therapeutics Inc STU:ANUA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XORTX Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

XORTX Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2.365/0
= %

XORTX Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.433/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
XORTX Therapeutics (STU:ANUA) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on XORTX Therapeutics and its competitors. According to the industry distribution chart, XORTX Therapeutics ranks #999999 out of 950 companies in the Biotechnology industry.
Is XORTX Therapeutics' OCF Margin % too high?
XORTX Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, XORTX Therapeutics ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, XORTX Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does XORTX Therapeutics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, XORTX Therapeutics ranks #999999 out of 950 companies for OCF Margin %. This places XORTX Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on XORTX Therapeutics and its competitors. XORTX Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XORTX Therapeutics stock overvalued right now?
XORTX Therapeutics (STU:ANUA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. XORTX Therapeutics' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For XORTX Therapeutics (STU:ANUA), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XORTX Therapeutics Business Description

Address 3710 - 33rd Street NW, Calgary, AB, CAN, T2L 2M1
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
26GF Score

Get the complete analysis for STU:ANUA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.75
Price